Literature DB >> 19933335

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

Isaac M Chiu1, Hemali Phatnani, Michael Kuligowski, Juan C Tapia, Monica A Carrasco, Ming Zhang, Tom Maniatis, Michael C Carroll.   

Abstract

During injury to the nervous system, innate immune cells mediate phagocytosis of debris, cytokine production, and axon regeneration. In the neuro-degenerative disease amyotrophic lateral sclerosis (ALS), innate immune cells in the CNS are activated. However, the role of innate immunity in the peripheral nervous system (PNS) has not been well defined. In this study, we characterized robust activation of CD169/CD68/Iba1+ macrophages throughout the PNS in mutant SOD1(G93A) and SOD1(G37R) transgenic mouse models of ALS. Macrophage activation occurred pre-symptomatically, and expanded from focal arrays within nerve bundles to a tissue-wide distribution following symptom onset. We found a striking dichotomy for immune cells within the spinal cord and PNS. Flow cytometry and GFP bone marrow chimeras showed that spinal cord microglia were mainly tissue resident derived, dendritic-like cells, whereas in peripheral nerves, the majority of activated macrophages infiltrated from the circulation. Humoral antibodies and complement localized to PNS tissue in tandem with macrophage recruitment, and deficiency in complement C4 led to decreased macrophage activation. Therefore, cross-talk between nervous and immune systems occurs throughout the PNS during ALS disease progression. These data reveal a progressive innate and humoral immune response in peripheral nerves that is separate and distinct from spinal cord immune activation in ALS transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933335      PMCID: PMC2791631          DOI: 10.1073/pnas.0911405106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Local self-renewal can sustain CNS microglia maintenance and function throughout adult life.

Authors:  Bahareh Ajami; Jami L Bennett; Charles Krieger; Wolfram Tetzlaff; Fabio M V Rossi
Journal:  Nat Neurosci       Date:  2007-11-18       Impact factor: 24.884

Review 2.  Why is Wallerian degeneration in the CNS so slow?

Authors:  Mauricio E Vargas; Ben A Barres
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

3.  Requirement of myeloid cells for axon regeneration.

Authors:  Benoit Barrette; Marc-André Hébert; Mohammed Filali; Kathleen Lafortune; Nicolas Vallières; Geneviève Gowing; Jean-Pierre Julien; Steve Lacroix
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

Review 4.  Retrograde axonal transport and motor neuron disease.

Authors:  Anna-Lena Ström; Jozsef Gal; Ping Shi; Edward J Kasarskis; Lawrence J Hayward; Haining Zhu
Journal:  J Neurochem       Date:  2008-04-01       Impact factor: 5.372

5.  CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

Authors:  David R Beers; Jenny S Henkel; Weihua Zhao; Jinghong Wang; Stanley H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

6.  Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP.

Authors:  G Feng; R H Mellor; M Bernstein; C Keller-Peck; Q T Nguyen; M Wallace; J M Nerbonne; J W Lichtman; J R Sanes
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

7.  T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

Authors:  Isaac M Chiu; Adam Chen; Yi Zheng; Bela Kosaras; Stefanos A Tsiftsoglou; Timothy K Vartanian; Robert H Brown; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

8.  The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis.

Authors:  Trent M Woodruff; Kerina J Costantini; James W Crane; Julie D Atkin; Peter N Monk; Stephen M Taylor; Peter G Noakes
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

9.  The membrane attack complex of the complement system is essential for rapid Wallerian degeneration.

Authors:  Valeria Ramaglia; Rosalind Helen Mary King; Michelle Nourallah; Ruud Wolterman; Rosalein de Jonge; Marja Ramkema; Miriam Ann Vigar; Sandra van der Wetering; Brian Paul Morgan; Dirk Troost; Frank Baas
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

10.  MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis.

Authors:  Jihong Kang; Serge Rivest
Journal:  J Cell Biol       Date:  2007-12-17       Impact factor: 10.539

View more
  86 in total

1.  Peripheral nerve inflammation in ALS mice: cause or consequence.

Authors:  Osamu Kano; David R Beers; Jenny S Henkel; Stanley H Appel
Journal:  Neurology       Date:  2012-02-29       Impact factor: 9.910

Review 2.  Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis.

Authors:  Katharina A Quinlan
Journal:  Integr Comp Biol       Date:  2011-10-11       Impact factor: 3.326

Review 3.  Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.

Authors:  Weihua Zhao; David R Beers; Stanley H Appel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

Review 4.  Glial cells in amyotrophic lateral sclerosis.

Authors:  T Philips; J D Rothstein
Journal:  Exp Neurol       Date:  2014-05-22       Impact factor: 5.330

5.  C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice.

Authors:  Christian S Lobsiger; Severine Boillée; Christine Pozniak; Amir M Khan; Melissa McAlonis-Downes; Joseph W Lewcock; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

6.  Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris.

Authors:  Xi Wang; Kai Cao; Xin Sun; Yongxiong Chen; Zhaoxia Duan; Li Sun; Lei Guo; Paul Bai; Dongming Sun; Jianqing Fan; Xijing He; Wise Young; Yi Ren
Journal:  Glia       Date:  2014-11-28       Impact factor: 7.452

7.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

Review 8.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

9.  A pilot trial of RNS60 in amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Mohamad J Alshikho; Sarah Luppino; James Chan; Lindsay Pothier; David Schoenfeld; Patricia L Andres; Suma Babu; Nicole R Zürcher; Marco L Loggia; Robert L Barry; Silvia Luotti; Giovanni Nardo; Maria Chiara Trolese; Serena Pantalone; Caterina Bendotti; Valentina Bonetto; Fabiola De Marchi; Bruce Rosen; Jacob Hooker; Merit Cudkowicz; Nazem Atassi
Journal:  Muscle Nerve       Date:  2018-12-26       Impact factor: 3.217

10.  Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

Authors:  Emiliano Trias; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Mariángeles Kovacs; Ivan C Moura; Joseph S Beckman; Olivier Hermine; Luis Barbeito
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.